Burcu Gülbağcı

5PUBLICATIONS
73CO-AUTHORS
Neurology and neuromuscular diseasesPredictive and prognostic markersOptical technologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 27, 2026
Beyond tumor burden: PET/CT-derived psoas muscle quality and survival outcomes in metastatic NSCLC patients treated with nivolumab.

|Feb 27, 2026
Short-Term Biceps Muscle Wasting Assessed by Serial Ultrasound as a Predictor of Survival Duration in Terminally Ill Cancer Patients: A Retrospective Cohort Study.

İrem Kıraç Utku, Nezahat Müge Çatıkkaş, Deniz Sevindik Günay

|Feb 19, 2026
Relationship Between Netrin-1 Staining and Neoadjuvant Treatment Response in HER2-Positive Locally Advanced Breast Cancer.

Burcu Gülbağcı, Gözde Çakırsoy Çakar, Ahmet Küçükarda

|Feb 13, 2026
Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (TOG).

Sercan On, Selin Cebeci, Zeynep Hande Turna

|Feb 11, 2026
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group.

Salih Tunbekici, Hamit Bal, Oguzcan Kınıkoglu

Pageof 1

Frequent Collaborators

2 joint publications

Ertugrul Bayram

2 joint publications

Teoman Sakalar

2 joint publications

Hayati Arvas

2 joint publications

Elif Sahin